Adalimumab in the therapy of uveitis in childhood
- PMID: 17322463
- PMCID: PMC1857669
- DOI: 10.1136/bjo.2006.108050
Adalimumab in the therapy of uveitis in childhood
Abstract
“Adalimumab is more effective” …?
Conflict of interest statement
Competing interests: The author has no financial interest in any product listed in the manuscript.
Comment on
-
Adalimumab in the therapy of uveitis in childhood.Br J Ophthalmol. 2007 Mar;91(3):319-24. doi: 10.1136/bjo.2006.103721. Epub 2006 Oct 11. Br J Ophthalmol. 2007. PMID: 17035274 Free PMC article.
References
-
- Gordon K B, Langley R G, Leonardi C.et al Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double‐blind, randomized controlled trial and open‐label extension study. J Am Acad Dermatol 200655598–606. - PubMed
-
- Suhler E B, Smith J R, Wertheim M S.et al A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. Arch Ophthalmol 2005123903–912. - PubMed
-
- Mushtaq B, Saeed T, Situnayake R D.et al Adalimumab for sight‐threatening uveitis in Behcet's disease. Eye. Published Online First: 7 April 2006. doi: 10.1038/sj.eye.6702352 - PubMed
-
- Galor A, Perez V L, Hammel J P.et al Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmology 2006113(12)2317–2323. - PubMed
-
- Vazquez‐Cobian L B, Flynn T, Lehman T J. Adalimumab therapy for childhood uveitis. J Pediatr 2006149572–575. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical